SR9011 | Interleukin Related interleukin-related.com

Product Name :
SR9011

Search keywords :
SR9011

drugId :
null

Target Vo:
Nuclear receptor subfamily 1 group D member 2

Target Vo Short Name :
NR1D2

Moa_Name:
Nuclear receptor subfamily 1 group D member 2 agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
The Scripps Research Institute Inc

Active Company_Name :
The Scripps Research Institute Inc

Active Indication_Name:
Metabolic Diseases

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tyrosine Hydroxylase Antibody
Bmi1 Antibody
NFAT1 Antibody: NFAT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100 kDa, targeting to NFAT1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts